Clinical Practice Guideline

Diagnosis and Treatment of Pheochromocytoma and Paraganglioma

June 19, 2014

Full Guideline: Pheochromocytoma and Paraganglioma: An Endocrine Society Clinical Practice Guideline
JCEM June 2014

Jacques W. M. Lenders, Quan-Yang Duh, Graeme Eisenhofer, Anne-Paule Gimenez-Roqueplo, Stefan K. G. Grebe, Mohammad Hassan Murad, Mitsuhide Naruse, Karel Pacak, William F. Young, Jr.

Objective:

The aim was to formulate clinical practice guidelines for pheochromocytoma and paraganglioma (PPGL).

Conclusions:

  • The Task Force recommends that initial biochemical testing for PPGLs should include measurements of plasma free or urinary fractionated metanephrines.
  • Consideration should be given to preanalytical factors leading to false-positive or false-negative results.
  • All positive results require follow-up.
  • Computed tomography is suggested for initial imaging, but magnetic resonance is a better option in patients with metastatic disease or when radiation exposure must be limited.
  • I-metaiodobenzylguanidine scintigraphy is a useful imaging modality for metastatic PPGLs.
  • We recommend consideration of genetic testing in all patients, with testing by accredited laboratories.
  • Patients with paraganglioma should be tested for SDHx mutations, and those with metastatic disease for SDHB mutations.
  • All patients with functional PPGLs should undergo preoperative blockade to prevent perioperative complications.
  • Preparation should include a high-sodium diet and fluid intake to prevent postoperative hypotension.
  • We recommend minimally invasive adrenalectomy for most pheochromocytomas with open resection for most paragangliomas.
  • Partial adrenalectomy is an option for selected patients.
  • Lifelong follow-up is suggested to detect recurrent or metastatic disease.
  • We suggest personalized management with evaluation and treatment by multidisciplinary teams with appropriate expertise to ensure favorable outcomes.

arrow Read the Full Guideline

CME

Certified Medical Minute

Watch this expert CME/CE-certified presentation highlighting expert recommendations on the variety of continuous glucose monitoring devices for optimizing management of individual patients with type 1 and type 2 diabetes

Comparison of Available and Emerging CGM Technology

Watch this expert CME/CE-certified presentation highlighting expert recommendations on the variety of continuous glucose monitoring devices for optimizing management of individual patients with type 1 and type 2 diabetes

Back to top
Short on time?

We'll come to you...

Get updates on the latest breakthroughs, clinical practice guidelines, and career development opportunities, straight to your inbox

Then take the next step: Set up your free website account and get exclusive access to even more great tools & content!